Literature DB >> 12898798

Gender differences in cardiovascular risk factors.

Giuseppe Mercuro1, Sandra Zoncu, Francesco Dragoni.   

Abstract

Coronary heart disease is less common in premenopausal women compared to age-matched men. This difference disappears in the post-fertile years, and is presumably related to the reduced levels of female sex hormones, with subsequent metabolic and hemodynamic modifications. Ovarian exhaustion induces a more atherogenic lipid profile, which may partly explain the increased risk of cardiovascular disease observed in post-fertile women as compared to age-matched fertile women. After the menopause, the combination of aging and estrogen deficiency negatively affects glucose metabolism. Diabetes mellitus blunts the beneficial condition associated with the female gender; furthermore, it increases the incidence of myocardial infarction, claudication and stroke in women more than in men. Finally, the unfavorable effects of menopause on the coronary risk seem to be mediated partly by changes in clotting and fibrinolytic factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898798

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  3 in total

1.  Medroxyprogesterone acetate and dihydrotestosterone induce coronary hyperreactivity in intact male rhesus monkeys.

Authors:  Rajesh G Mishra; R Kent Hermsmeyer; Koichi Miyagawa; Philip Sarrel; Barry Uchida; Frank Z Stanczyk; Kenneth A Burry; D Roger Illingworth; Frank J Nordt
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

2.  Sex-specific associations between screen time and lipoprotein subfractions.

Authors:  Alexis C Frazier-Wood; Ingrid B Borecki; Mary F Feitosa; Paul N Hopkins; Caren E Smith; Donna K Arnett
Journal:  Int J Sport Nutr Exerc Metab       Date:  2013-08-26       Impact factor: 4.599

Review 3.  Menopause, the metabolic syndrome, and mind-body therapies.

Authors:  Kim E Innes; Terry Kit Selfe; Ann Gill Taylor
Journal:  Menopause       Date:  2008 Sep-Oct       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.